AIV Logo AIV Assistant

Loading...

 Logo Neuronetics, Inc. - STIM 3.74 USD

EPS
-1.32
P/B
1.98
ROE
-100.13
Beta
2.22
Target Price
2.67 USD

3.740 USD

3.740 USD

Daily: +0.00%
Key Metrics

EPS: -1.32

Book Value: 1.18

Price to Book: 1.98

Debt/Equity: 323.03

% Insiders: 11.100%

Growth

Revenue Growth: -0.07%

Estimates

Forward P/E: -3.48

Forward EPS: -0.62

Target Mean Price: 2.67

 Logo About Neuronetics, Inc. - (STIM)

Country: United States

Sector: Financials

Website: http://www.a-star.co

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Exchange Ticker
SET (Thailand) IRCP-R.BK
STU (Germany) NR1A.SG
NMS (United States) STIM

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion